1235 related articles for article (PubMed ID: 8557438)
21. Does BCG vaccination protect the newborn and young infants?
ten Dam HG; Hitze KL
Bull World Health Organ; 1980; 58(1):37-41. PubMed ID: 6991146
[TBL] [Abstract][Full Text] [Related]
22. The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada.
Cook VJ; Hernández-Garduño E; Kunimoto D; Hershfield ES; Fanning EA; Hoeppner VH; Elwood RK; FitzGerald JM;
Can Respir J; 2005 Apr; 12(3):134-8. PubMed ID: 15875064
[TBL] [Abstract][Full Text] [Related]
23. The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Sterne JAC; Abubakar I; Smith PG; Fine PEM; Vynnycky E; Watson JM; Elliman D; Lipman M; Rodrigues LC
Int J Epidemiol; 2018 Feb; 47(1):193-201. PubMed ID: 29025083
[TBL] [Abstract][Full Text] [Related]
24. Targeted BCG vaccination against severe tuberculosis in low-prevalence settings: epidemiologic and economic assessment.
Altes HK; Dijkstra F; Lugnèr A; Cobelens F; Wallinga J
Epidemiology; 2009 Jul; 20(4):562-8. PubMed ID: 19295437
[TBL] [Abstract][Full Text] [Related]
25. BCG scarring and improved child survival: a combined analysis of studies of BCG scarring.
Benn CS; Roth A; Garly ML; Fisker AB; Schaltz-Buchholzer F; Timmermann A; Berendsen M; Aaby P
J Intern Med; 2020 Dec; 288(6):614-624. PubMed ID: 32301189
[TBL] [Abstract][Full Text] [Related]
26. [Progress in research of bacillus calmette-guerin vaccination and repeated vaccination].
You NN; Liu Q; Zhu LM; Lu W
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1519-1523. PubMed ID: 30462965
[TBL] [Abstract][Full Text] [Related]
27. Effect of mass BCG vaccination at birth on the incidence of tuberculosis among Jewish children in Israel.
Zilber N; Simchen E; Wartski S; Marcus JH; Shakya GR
Isr J Med Sci; 1984 Dec; 20(12):1150-7. PubMed ID: 6519946
[TBL] [Abstract][Full Text] [Related]
28. Risk of tuberculosis infection and tuberculous meningitis after discontinuation of Bacillus Calmette-Guerin in Beijing.
Zhang LX; Tu DH; He GX; Ma ZQ; Nagelkerke NJ; Borgdorff MW; Enarson DA; Broekmans JF
Am J Respir Crit Care Med; 2000 Oct; 162(4 Pt 1):1314-7. PubMed ID: 11029337
[TBL] [Abstract][Full Text] [Related]
29. Risk factors associated with latent tuberculosis infection in Mexican American children.
Young J; O'Connor ME
Pediatrics; 2005 Jun; 115(6):e647-53. PubMed ID: 15930191
[TBL] [Abstract][Full Text] [Related]
30. Infant BCG vaccination and risk of pulmonary and extrapulmonary tuberculosis throughout the life course: a systematic review and individual participant data meta-analysis.
Martinez L; Cords O; Liu Q; Acuna-Villaorduna C; Bonnet M; Fox GJ; Carvalho ACC; Chan PC; Croda J; Hill PC; Lopez-Varela E; Donkor S; Fielding K; Graham SM; Espinal MA; Kampmann B; Reingold A; Huerga H; Villalba JA; Grandjean L; Sotgiu G; Egere U; Singh S; Zhu L; Lienhardt C; Denholm JT; Seddon JA; Whalen CC; García-Basteiro AL; Triasih R; Chen C; Singh J; Huang LM; Sharma S; Hannoun D; Del Corral H; Mandalakas AM; Malone LL; Ling DL; Kritski A; Stein CM; Vashishtha R; Boulahbal F; Fang CT; Boom WH; Netto EM; Lemos AC; Hesseling AC; Kay A; Jones-López EC; Horsburgh CR; Lange C; Andrews JR
Lancet Glob Health; 2022 Sep; 10(9):e1307-e1316. PubMed ID: 35961354
[TBL] [Abstract][Full Text] [Related]
31. Bacillus Calmette-Guérin (BCG) vaccination patterns in the province of Québec, Canada, 1956-1974.
Rousseau MC; Conus F; Kâ K; El-Zein M; Parent MÉ; Menzies D
Vaccine; 2017 Aug; 35(36):4777-4784. PubMed ID: 28705514
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of bacille Calmette-Guérin immunisation programs in Australia.
Khandaker G; Beard FH; Dey A; Coulter C; Hendry AJ; Macartney KK
Commun Dis Intell Q Rep; 2017 Mar; 41(1):E33-E48. PubMed ID: 28385137
[TBL] [Abstract][Full Text] [Related]
33. The rate of adverse events following BCG vaccination in Poland.
Krysztopa-Grzybowska K; Paradowska-Stankiewicz I; Lutyńska A
Przegl Epidemiol; 2012; 66(3):465-9. PubMed ID: 23230718
[TBL] [Abstract][Full Text] [Related]
34. [Tuberculosis prevalence survey in Japan].
Shimao T
Kekkaku; 2009 Nov; 84(11):713-20. PubMed ID: 19999593
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness and cost-effectiveness of first BCG vaccination against tuberculosis in school-age children without previous tuberculin test (BCG-REVAC trial): a cluster-randomised trial.
Pereira SM; Barreto ML; Pilger D; Cruz AA; Sant'Anna C; Hijjar MA; Ichihara MY; Santos AC; Genser B; Rodrigues LC
Lancet Infect Dis; 2012 Apr; 12(4):300-6. PubMed ID: 22071248
[TBL] [Abstract][Full Text] [Related]
36. Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.
Abbott S; Christensen H; Welton NJ; Brooks-Pollock E
Euro Surveill; 2019 Dec; 24(49):. PubMed ID: 31822330
[TBL] [Abstract][Full Text] [Related]
37. [Tuberculosis control strategy in the 21st century in Japan--for elimination of tuberculosis in Japan].
Aoki M
Kekkaku; 2001 Jul; 76(7):549-57. PubMed ID: 11517563
[TBL] [Abstract][Full Text] [Related]
38. Effectiveness of Bacillus Calmette-Guérin vaccination against severe childhood tuberculosis in China: a case-based, multicenter retrospective study.
Liao Q; Zheng Y; Wang Y; Ye L; Liu X; Jiao W; Liu Y; Zhu Y; Jia J; Sun L; Shen A; Wan C
Int J Infect Dis; 2022 Aug; 121():113-119. PubMed ID: 35429637
[TBL] [Abstract][Full Text] [Related]
39. [Contemporary status of BCG vaccine in the world and in Serbia].
Pesut D
Med Pregl; 2004; 57 Suppl 1():37-40. PubMed ID: 15686220
[TBL] [Abstract][Full Text] [Related]
40. A systematic review of BCG vaccination policies among high-risk groups in low TB-burden countries: implications for vaccination strategy in Canadian indigenous communities.
Faust L; Schreiber Y; Bocking N
BMC Public Health; 2019 Nov; 19(1):1504. PubMed ID: 31711446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]